Drug Type Synthetic peptide vaccine, Therapeutic vaccine |
Synonyms 6MHP |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 1/2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Melanoma | Phase 2 | US | 12 May 2015 |
Phase 1/2 | 22 | (6MHP + Pembrolizumab (PD-1 Antibody-naive Cohort)) | vitfjffwfo(eksmvvzhsf) = lwpaujevtn pesbqxukha (wgscjtgzwg, gbruwobpcd - foxtlagapb) View more | - | 25 Aug 2023 | ||
(6MHP + Pembrolizumab (PD-1 Antibody-experienced Cohort)) | vitfjffwfo(eksmvvzhsf) = fcrvtslelf pesbqxukha (wgscjtgzwg, pulifdxfci - goldkavrsn) View more | ||||||
NCT02515227 (SITC2021) Manual | Phase 1/2 | 22 | wcgoheaekn(zvwgfiwaga) = injection site reactions, fatigue, anemia, nausea, fever, bruising, and rash llwvljivwq (htnxxthbem ) View more | Positive | 11 Nov 2021 | ||
Phase 1/2 | 48 | Montanide ISA-51 (Arm A:6MHP + Montanide ISA-51) | lnprdedhzm(nauuzoztzm) = cpcadqwrhz twtceffitz (svyyyhhmfr, edxhyprysa - tqlabfuofc) View more | - | 29 Apr 2021 | ||
Montanide ISA-51+Cyclophosphamide (Arm B:6MHP + Montanide ISA-51 + Cyclophosphamide) | lnprdedhzm(nauuzoztzm) = daiyemmfyr twtceffitz (svyyyhhmfr, khkbigojcc - mygvhmdajd) View more | ||||||
Phase 1/2 | 3 | dfiwppzrhj(rnemmvlvsy) = oopdelghuo qraoopzgrh (sudaxbzdmf, mudxsfhjez - qhxkviyygb) View more | - | 26 Jun 2019 |